Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder

References

• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Fayyad J, De Graaf R, Kessler R, . Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409
   PubMed Web of Science ®Google Scholar
• . Adler LA, Chua HC. Management of ADHD in adults. J Clin Psychiatry. 2002;63( suppl 12):29–35
   PubMed Web of Science ®Google Scholar
• . Gallagher R, Blader J. The diagnosis and neuropsychological assessment of adult attention deficit/hyperactivity disorder. Scientific study and practical guidelines. Ann N Y Acad Sci. 2001;931:148–171
   PubMed Web of Science ®Google Scholar
• . Adler L, Shaw D, Sitt D, Maya E, Morrill MI. Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Prim Psychiatry. 2009;16(5):57–63
   Google Scholar
• . Baron D. The impact of comorbid disorders on adults with ADHD. Psychiatr Times. 2007;( suppl 2):7–10
   Google Scholar
• . Goodman DW. The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract. 2007;13(5):318–327
   PubMedGoogle Scholar
• . Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol. 2010;25(3):157–173
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524–540
   PubMed Web of Science ®Google Scholar
• . Greenfield B, Hechman L. Treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother. 2005;5(1):107–121
   PubMedGoogle Scholar
• . Adler LA, Zimmerman B, Starr HL, . Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 2009;29(3):239–247
   PubMed Web of Science ®Google Scholar
• . Faraone SV. Interpreting estimates of treatment effects. Implications for managed care. P & T. 2008;33(12):700–701
   PubMedGoogle Scholar
• . Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004;24(1):24–29
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754–763
   PubMed Web of Science ®Google Scholar
• . Cohen J. Quantitative methods in psychology: a power primer. Psychol Bull. 1992;112(1):155–159
   PubMed Web of Science ®Google Scholar
• . Faraone SV. Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. P&T. 2009;34(12):678–694
   PubMedGoogle Scholar
• . Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther. 2006;28(11):1892–1908
   PubMed Web of Science ®Google Scholar
• . Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6:317–327
   PubMed Web of Science ®Google Scholar
• . Adler LA, Goodman DW, Kollins SH, ; 303 Study Group.Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Wigal SB, Kollins SH, Childress AC, Adeyi B. Efficacy and tolerability of Lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day. Child Adolesc Psychiatry Ment Health. 2010;4(1):32
   PubMedGoogle Scholar
• . Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J; 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using the adult workplace environment design. Behav Brain Funct. 2010;6:34
   PubMed Web of Science ®Google Scholar
• . Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10(1):92–111
   PubMedGoogle Scholar
• . American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000:85–93
   Google Scholar
• . DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press. 1998;251
   Google Scholar
• . Faries DE, Yalcin I, Harder D, Heiligenstein JH. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord. 2001;5(2):107–115
   Google Scholar
• . Brams M, Moon E, Pucci M, Lopez FA. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010;26(8):1809–1825
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer TJ, Biederman J, . The internal consistency and validity of the attention-deficit/hyperactivity disorder rating scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trial. J ADHD Relate Disord. 2009;1(1):14–24
   Google Scholar
• . Stein MA, Sarampote CS, Waldman ID, . A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2003;112(5):e404
   PubMed Web of Science ®Google Scholar
• . Curtin F, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Stat Med. 2002;21(15):2131–2144
   PubMed Web of Science ®Google Scholar
• . Weisler RH, Biederman J, Spencer TJ, . Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625–639
   PubMed Web of Science ®Google Scholar
• . Rösler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):120–129
   PubMed Web of Science ®Google Scholar
• . Medori R, Ramos-Quiroga JA, Casas M, . A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63(10):981–989
   PubMed Web of Science ®Google Scholar
• . Biederman J, Mick E, Surman C, . A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–835
   PubMed Web of Science ®Google Scholar
• . Jain U, Hechtman L, Weiss M, . Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry. 2007;68(2):268–277
   PubMed Web of Science ®Google Scholar
• . Young J, Mattingly G, Weisler R, . Response and symptomatic remission in a long-term trial of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Poster presented at: American Psychiatric Association's 162nd Annual Meeting; May 16–21, 2009; San Francisco, CA
   Google Scholar
• . Swanson JM, Kraemer HC, Hinshaw SP, . Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40(2):168–179
   PubMed Web of Science ®Google Scholar